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Abstract
Objective—To test the hypothesis that SCNA can adequately estimate the cardiac sympathetic 
tone and the effects of cryoablation of the stellate ganglion in dogs with pacing-induced HF.
Background—Recording of subcutaneous nerve activity (SCNA) is new method to estimate 
sympathetic tone in dogs. Heart failure (HF) is known to increase sympathetic tone and atrial 
arrhythmias.
Methods—Twelve dogs with pacing-induced heart failure were studied using implanted 
radiotransmitters to record the stellate ganglia nerve activity (SGNA), vagal nerve activity (VNA) 
and SCNA. Among them, 6 dogs (Ablation Group) underwent bilateral stellate ganglia 
cryoablation before the rapid ventricular pacing and the remaining 6 dogs (Control Group) had 
rapid ventricular pacing only. In both groups, SCNA was compared to SGNA and the occurrence 
of arrhythmias.
Results—SCNA invariably increased preceding 360 identified atrial tachyarrhythmia episodes in 
the 6 control dogs before and after induction of HF. SCNA and SGNA correlated in all dogs with 
an average correlation coefficient of 0.64 (95% CI 0.58–0.70). Cryoablation of bilateral stellate 
ganglia significantly reduced SCNA from 0.34 ± 0.033 µV to 0.25 ± 0.028 µV (p=0.03) and 
eliminated all atrial tachyarrhythmias.
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Conclusions—SCNA can be used to estimate cardiac sympathetic tone in dogs with pacing-
induced HF. Cryoablation of the stellate ganglia reduced SCNA and arrhythmia vulnerability.
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Introduction
Sympathetic tone measured by stellate ganglion nerve activity (SGNA) has been shown to 
influence atrial electrophysiology and the onset of atrial arrhythmias. We(1–3) recently 
proposed a new method (neuECG) to simultaneously record the electrocardiogram (ECG) 
and subcutaneous nerve activity (SCNA) using bipolar electrodes placed under the skin. The 
electrical signals were low pass filtered to optimize ECG and high pass filtered to reveal 
SCNA. Because a good correlation has been shown between SCNA and the simultaneously 
recorded stellate ganglia nerve activity (SGNA),(1) we proposed that the SCNA may be used 
to estimate cardiac sympathetic tone. The non-invasive estimation of sympathetic tone may 
provide new insights into the mechanisms of cardiac arrhythmias and may also provide a 
direct method to measure the success of neuromodulation procedures. Ogawa et al(4,5) had 
previously performed two studies in dogs with pacing-induced heart failure (HF). In the first 
study, it was shown that HF increases SGNA and occurrence of cardiac arrhythmias.(4) In a 
second study, using the same HF model, cryoablation of the caudal half of the left and right 
stellate ganglia and T2-T4 thoracic sympathetic ganglia was performed. It was shown that 
cryoablation significantly reduced both SGNA and paroxysmal atrial tachycardia (PAT) 
episodes.(5) The data from these studies have not been analyzed to determine if SCNA 
increased after induction of HF and decreased after cryoablation of the stellate ganglion. We 
retrieved the data from both studies and manually analyzed de novo the SGNA and atrial 
tachyarrhythmia episodes. We also performed analyses of SCNA using the methods 
previously reported.(1) The purpose of the present study was to test the hypothesis that (1) 
HF increases both SCNA and SGNA, (2) both SCNA and SGNA preceded the onset of PAT 
at baseline and after induction of HF and (3) cryoablation of the stellate ganglion can reduce 
both SCNA and SGNA in ambulatory dogs.
Methods
Original data from two previously published reports(4,5) were retrieved and manually 
analyzed. The research protocols were approved by the Institutional Animal Use and Care 
Committees of the Cedars-Sinai Medical Center, Los Angeles, California, and the Indiana 
University School of Medicine at the Methodist Research Institute, Indianapolis, Indiana.
Surgical preparations
The surgical preparations have been described previously. Briefly, all surgeries were 
performed under isoflurane anesthesia. Subcutaneous bipolar electrodes were placed in the 
left thorax of dogs, 6–10 cm apart to record SCNA. The electrodes were stainless steel wires 
with the terminal 5mm of the wires stripped of their insulation and used for electrical 
recording. The leads were attached to a Data Science International D70-EEE 
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radiotransmitter (DSI; St. Paul, Minnesota) which was also implanted in the subcutaneous 
space. In the same procedure, through a left thoracotomy, a pair of bipolar electrodes from 
the DSI radiotransmitter was sutured onto the left stellate ganglion (LSG) to record SGNA. 
Another set of bipolar electrodes were placed on the left thoracic vagal nerve to record vagal 
nerve activity (VNA).
Experimental protocols
In all dogs, a pacing lead was implanted in the right ventricular (RV) apex and connected to 
a Medtronic Itrel neurostimulator for high rate ventricular pacing. After recovery from the 
initial surgery, the dogs had 2 weeks of continuous baseline ambulatory monitoring. After 
the baseline recording, the first group of 6 dogs (Group 1) underwent RV pacing at 150 bpm 
for 3 days, at 200 bpm for 3 days, and then at 250 bpm for 3 weeks to induce HF which was 
confirmed by Echocardiographic data.(6) The pacemakers were then turned off to allow 
ambulatory monitoring for additional two weeks. In the second group of 6 dogs (Group 2), 
the caudal half of the left stellate ganglion and T2-T4 thoracic sympathetic ganglia were 
cryoablated through the left thoracotomy using a 7-cm SurgiFrost probe (CryoCath 
Technologies, Inc., Montreal, Canada) during the same surgery where the DSI 
radiotransmitter was implanted for monitoring of SCNA, SGNA, and VNA. The dogs then 
underwent the same surgery and protocol for implantation of the Medtronic Itrel 
neurostimulator for subsequent high rate ventricular pacing to induce HF. These dogs were 
also monitored for two weeks before and after induction of HF.
Data analyses
Identifying Paroxysmal Atrial Tachyarrhythmias—Recordings from the bipolar 
electrodes connected to the radiotransmitter were analyzed to obtain SCNA, SGNA, VNA, 
and ECG using custom-written software. The impedance of the electrodes was 0.7 – 0.8 Ω 
and the recordings were amplified 10000 times and sampled at 1000Hz. We obtained an 
ECG for analyses by applying a bandpass filter (5–100 Hz) on the vagus nerve channel or 
subcutaneous nerve channel of the radiotransmitter. SCNA, SGNA, and VNA were obtained 
by high pass filtering at 150 Hz. The SGNA and VNA were rectified and integrated over 1 
minute. The SCNA was also rectified and integrated over the same minute after adjusting the 
SCNA with wavelet analysis as described previously.(7) In particular, spike-triggered 
averaging was performed to allow removal of the ventricular electrogram from the SCNA by 
subtracting a ventricular electrogram template obtained from averaged ventricular 
electrograms in the observational window. Finally, the ECG was used to calculate the heart 
rate over the same minute. The sum of all digitized nerve activity was then divided by the 
total number of samples during the same time period to obtain averaged SGNA (aSGNA), 
averaged SCNS (aSCNA) and averaged VNA (aVNA) per sample. Nerve activity was also 
quantified by determining the number of spikes and bursts within the nerve activity.(8) The 
filtered and rectified signals from a 24-hour recording were integrated over a 100 ms sliding 
window. Within this integrated signal, nerve spikes and bursts of nerve activity were 
detected. A spike was defined as the continuous time period where the amplitude is above 
the threshold value. Each spike’s duration and average amplitude were measured within that 
time period. The threshold value was calculated as 3 times the baseline noise level, which 
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was considered to be the lowest 10th percentile of all values during the 24-hour recording. 
Spikes with an inter-spike interval of less than 5 seconds were grouped into bursts.
The aSGNA, aSCNA, aVNA, and heart rate were calculated every hour of a 24-hour period 
(2:00 pm to 2:00 pm the next day) before pacing at baseline and of every hour of the 24-hour 
period (2:00 pm to 2:00 pm the next day) immediately after pacing was stopped. In order to 
avoid periods of dropped radiotransmission or artifactual noise caused by movement of the 
dog, which was greater than nerve activity, the first 10 analyzable minutes of each hour were 
used for the calculation of the averaged nerve activity and heart rate.
Paroxysmal atrial tachyarrhythmias were defined as episodes of tachycardia (≥ 175 bpm) 
with abrupt onset (>50 bpm/sec) and a duration of > 5 s. Of these episodes, half were 
randomly selected for P wave analysis. This analysis involved comparing the P waves before 
the initiation of the tachycardia to the P waves during the tachycardia episode and analyzing 
the changes in P wave morphology and PR interval.
Statistical Analysis
The averaged nerve activities were compared between the control dogs and cryoablated dogs 
using one-sided student’s t-tests both before pacing and after pacing. In addition, the aSCNA 
for each dog was used to look at the effect of ventricular pacing on both control and 
cryoablated dogs by one-sided paired t-tests. The data were presented as mean ± standard 
deviation. In order to test for circadian variation, generalized additive mixed-effects models 
were fitted to the longitudinal data. A Pearson Correlation Coefficient was used to compare 
the SCNA and SGNA between the Control Group and the Ablation Group for 24 hours 
before and after pacing. A p value of ≤ 0.05 was considered to be significant.
Results
Effect of Stellate Ganglion Cryoablation on Nerve Activity
The Group 1 dogs did not have ablation while the Group 2 dogs had stellate ganglion 
ablation during the first surgery. Figure 1 shows that at baseline (before rapid ventricular 
pacing), aSGNA was significantly lower in the Group 2 dogs (0.56 ± 0.13 µV) than Group 1 
dogs (1.14 µV ± 0.11 µV) (p = 0.003), indicating ablation significantly reduced aSGNA. 
aSCNA was also significantly lower in Group 2 versus Group 1 dogs (0.25 µV ± 0.028 µV 
vs 0.34 µV ± 0.033 µV, p =0.03). The aVNA was lower in Group 2 (0.21 µV ± 0.0068 µV) 
than in Group 1 (0.48 µV± 0.066 µV, p=0.001) dogs. The heart rate (HR) was also lower in 
Group 2 (88 ± 7.9 bpm) than Group 1 (109 ± 4.0 bpm, p=0.02). Consistent with the previous 
report,(4) rapid ventricular pacing induced HF increased the nerve activities in both groups 
of dogs. Figure 2 shows the differences between Group 1 and Group 2 dogs after HF had 
been induced. As shown in that figure, the Group 2 dogs had lower nerve activities than 
Group 1 dogs, but the differences did not reach statistical significance for aSCNA and 
aSGNA. The aSCNA was 0.28 ± 0.024 µV in Group 2 and 0.43 ± 0.079 µV in Group 1 
(p=0.06). The aSGNA was 0.91 ± 0.27 µV for Group 2 and 1.23 ± 0.27 µV for Group 1 
(p=0.21). The VNA was 0.21 µV ± 0.011 µV for Group 2 and 0.55 µV ± 0.082 µV for Group 
1 (p=0.001). The HR was 87 ± 4.9 bpm for Group 2 and 96 ± 3.9 bpm for Group 1 (p=0.11). 
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The nerve activity was also quantified by detecting the spikes and bursts of activity within 
the nerve recording. Figure 3 shows that the amplitude of the bursts was significantly 
decreased after cryoablation for each type of nerve recording (SCNA, SGNA, and VNA). 
While there was no significant change in the burst frequency, due to the significant reduction 
in burst amplitude total nerve activity is reduced.
SCNA and Atrial Tachyarrhythmias
Dogs normally have PAT at baseline.(9) Consistent with that report, we were able to identify 
a total of 243 PAT episodes in 6 Group 1 dogs during a 24-hour period of monitoring at 
baseline and 117 PAT episodes after induction of HF by rapid pacing. Our de novo analyses 
confirmed the previous report that no PAT episodes were present in Group 2 dogs either at 
baseline or after rapid ventricular pacing.(6)
In all PAT episodes, an increase in the SCNA and SGNA correlated with the onset of the 
tachycardia (Figure 4). At the arrows labeled A and B, the SGNA and SCNA respectively 
begin to increase dramatically. The heart rate also increased suddenly, increasing at a rate of 
87 beats/minute per second (abrupt onset). The heart rate increased to greater than 175 BPM 
for over 7 seconds, fulfilling the diagnostic criteria for PAT. In all episodes, as in this 
example, increased SCNA were closely related to increases in SGNA during PAT episodes.
P wave changes were found in most randomly selected episodes of arrhythmias including P 
wave morphology changes and PR interval shortening as shown in Figure 5. In the atrial 
tachyarrhythmia in Figure 4, the P wave before the tachycardia started with a biphasic P 
wave with an initial upward phase followed by a negative phase as shown in panel A, but 
after the tachycardia, the P wave was initially negative with a small positive phase, then was 
even more negative as shown in panel B. Furthermore, the PR interval before the tachycardia 
was 125 ms and during the tachycardia the PR interval shortened to 105 ms. These findings 
indicate that the PAT episodes are unlikely to be sinus tachycardia.
Correlation between SGNA and SCNA
The nerve activity of stellate ganglia and subcutaneous nerves for both Group 1 and Group 2 
at baseline and after pacing were compared by plotting SGNA by SCNA. Linear regression 
was then used to fit the data and calculate the correlation coefficient. Figure 6 shows the 
results for Dog A including the correlation coefficient of r = 0.61 and p < 0.0005. The 
correlation coefficient and p value for each dog both before pacing and after pacing is shown 
in Table 1. In general, SCNA correlated moderately well with SGNA with an average of all 
the correlation coefficients of all dogs at 0.64 (95% CI 0.58–0.70). To compare the two 
groups, before pacing the mean difference between the ablation group and the control group 
(ablation - control) is 0.2567 (p = 0.01). After pacing the mean difference between the 
ablation group and the control group (ablation - control) is −0.035 (p = NS).
Circadian Variation
Figure 7 summarizes the SCNA data for all dogs. The SCNA had a significant circadian 
variation (p<0.001) when fitted to a generalized additive mixed-effects model. Figure 8 
shows the generalized additive mixed effect model fitted to the SCNA data. Previous studies 
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have shown a similar significant circadian variation for the SGNA.(5) Compared to the 
SCNA in Figure 7A, they both show a progressive increase in the morning hours with a 
secondary increase in the late afternoon.
Discussion
Using SCNA to measure sympathetic tone
Heart failure is characterized by increased sympathetic tone and cardiac arrhythmias.(4) The 
sympathetic nerve activity as measured by microneurography is reduced by cardiac 
resynchronization therapy (CRT) in the responders, but not in non-responders.(10) However, 
because microneurography techniques are difficult to perform and cannot be used in 
ambulatory patients, sympathetic nerve activity measurements have not been clinically 
useful in assessing the effects of CRT or other neuromodulation methods. The results of this 
study suggest that the SCNA might be a useful method to directly measure sympathetic tone 
in HF, and determining the effects of HF therapy. A second possible use of SCNA is to 
determine if cardiac arrhythmias are triggered by sympathetic activation. A previous study 
showed that SCNA was observed before a majority of episodes of ventricular tachycardia 
and ventricular fibrillation in an ambulatory canine model of sudden cardiac death.(2) In the 
present study we have shown that SCNA preceded the onset of all PAT episodes both at 
baseline and after the induction of HF. These findings suggest that SCNA can be useful in 
determining whether or not PAT was caused by sympathetic activation.
Sources of SCNA
Axonal tracer studies have shown that a significant portion of the skin sympathetic nerves of 
the neck and upper thorax originate from the ipsilateral stellate ganglion.(11,12) Several 
other studies have demonstrated a strong relationship between sympathetic nerve structures 
in the chest and skin nerves. Donadio et al have shown in skin biopsies an abundance of 
sympathetic nerves in arteriovenous anastomosis, arrector pilorum muscles, and arterioles.
(13) Baron et al showed in axonal tracer studies that nearly all skin sympathetic nerve 
somata are located in the middle cervical and stellate ganglia.(11) The middle cervical 
ganglion and the stellate ganglion are highly interconnected to intrinsic cardiac neurons. In 
addition, it has been shown that SCNA can be used as an estimate of sympathetic tone,(1) 
and is more accurate than heart rate variability.(14) The current study confirms that SGNA 
and SCNA are closely related as they both increase before the onset of paroxysmal atrial 
tachyarrhythmias and both decrease after cryoablation.
Effects of LSG ablation on SCNA
Previous studies have shown that the right stellate ganglion (RSG) controlled heart rate and 
only had an effect on blood pressure after the left stellate ganglion was completely resected. 
This suggests that the RSG innervates the sinus node and plays a role in regulating the heart 
rate. The left stellate ganglion (LSG) controls blood pressure and is thought to be the main 
influence in cardiac sympathetic control.(15) In a separate canine study, it was demonstrated 
that LSG stimulation significantly increased AF inducibility over RSG stimulation. 
Removing the LSG significantly reduced the incidence of AF.(16) However, in a clinical 
study, both RSG and LSG block showed similar results in reduced AF inducibility and 
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duration.(17) In addition to controlling atrial arrhythmias in canine models,(18) LSG 
ablation is known to be effective in decreasing sympathetic outflow and controlling 
ventricular arrhythmias.(19–22) In animal experiments, it has also been shown that partial 
LSG ablation can reduce or eliminate PAT in ambulatory canine models.(5,18) Left cardiac 
sympathetic denervation (LCSD) has been used as a therapeutic option for patients with 
catecholaminergic polymorphic ventricular tachycardia (CPVT) that have recurrent VF/VT 
episodes even with β-blocker therapy. Surgical approaches include thoracoscopic, 
transaxillary, and supraclavicular to expose the left-sided sympathetic chain from T4 – T1. 
Resection or ablation of the sympathetic ganglia from T1–T2 then has shown to have a 
positive effect in these patients. A more minimally invasive procedure using video-assisted 
thoracic surgery to perform LCSD has also proven to be effective in reducing cardiac events. 
However, even though we have previously shown that LCSD therapy with cryoablation can 
be used as a therapy for atrial arrhythmias, it is still not a commonly used approach as a 
clinical therapeutic option for atrial arrhythmias.
If SGNA is a source of SCNA, then partial LSG ablation should reduce the SCNA. The 
latter findings would further support the validity of SCNA in estimating SGNA. However, as 
shown in Figure 1, the LSG ablation seems to have more effects on aSGNA than aSCNA. 
One reason is that the subcutaneous nerves in the thorax may not all come from the LSG. 
Therefore, the baseline correlation between aSGNA and aSCNA was only moderate. A 
second reason is that LSG is a large nerve structure that generates strong electrical signals. 
Because of the high signal to noise ratio, the amplitude of reduction of SGNA after 
cryoablation is easier to visualize. In contrast, the subcutaneous nerves are small (average < 
1 µV at baseline) and have a smaller signal to noise ratio. Given that inherent noise of the 
recording system is a significant portion of the signal, a reduction of SCNA may not be as 
apparent after LSG ablation. Monitoring SCNA has many advantages over monitoring 
SGNA as an indicator of sympathetic nerve activity. Monitoring SGNA or other indicators 
of sympathetic nerve activity have involved an open chest procedure to implant electrodes 
on the stellate ganglion or other nerve structures. On the other hand, implantation of 
subcutaneous electrodes in the chest could be accomplished much less invasively. In 
addition, the study of subcutaneous nerve activity may lead to the use of surface electrodes 
for the monitoring of sympathetic nerve activity. Preliminary results have shown that it is 
possible to record the skin sympathetic nerve activity using ordinary ECG patch electrodes.
(3,23) For these reasons, SCNA may be a useful tool in minimally invasively monitoring 
sympathetic nerve activity involved in the arrhythmogenesis of atrial tachyarrhythmias and 
in estimating the efficacy of neuromodulation procedures.
Study Limitations
The electrical signals within the recordings from subcutaneous electrodes may come from 
multiple sources including low frequency motion artifacts, ECG, respiratory muscle activity, 
and nerve activities. While some noise can be effectively filtered with conventional filters, 
the ECG can contain high frequency content that is within the range of the frequency 
bandwidth of the nerve activity. Therefore, we decided to use a wavelet filter to filter out 
much of the ECG as we have done in previous studies with large ECG signals accompanying 
the nerve activity of interest.(7) While integrated SCNA showed a significant correlation 
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with integrated SGNA, integrated wavelet SCNA appeared to have a greater correlation with 
integrated SGNA. The dogs do not have sweat glands in the thorax where the recordings 
were made. Whether or not sweating affects the SCNA recording cannot be determined in 
this study.
In addition, our study used widely spaced electrodes to monitor subcutaneous nerve activity. 
Other studies in our lab have used more narrow spaced electrodes with varying success.(1,3) 
When using the Data Science International D70-EEE radiotransmitter with narrow spaced 
electrodes, the bandwidth and sampling rate of the device makes the signal to noise ratio 
insufficient to accurately monitor subcutaneous nerve activity. However, when using narrow 
spaced electrodes with recording equipment capable of recording with higher bandwidth and 
higher sampling rate of 10,000Hz, we were able to high pass filter at 500Hz, improving the 
signal to noise ratio and increasing the accuracy of monitoring the subcutaneous nerve 
activity.(1)
Conclusion
Subcutaneous nerve activity correlated with SGNA and the onset of arrhythmias. 
Cryoablation of the stellate ganglia reduced the SCNA, further validating the use of SCNA 
to estimate cardiac sympathetic tone. This study suggests that using equipment with an 
appropriate bandwidth and sampling rate, recording subcutaneous nerve activity with an 
implantable device may be possible, and the SCNA can be used as a surrogate for SGNA.
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AT atrial tachycardia
ECG electrocardiogram
Shelton et al. Page 9
JACC Clin Electrophysiol. Author manuscript; available in PMC 2019 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
HF heart failure
HR heart rate
HRV heart rate variability
LSG left stellate ganglion
RV right ventricle
SCNA subcutaneous nerve activity
SGNA stellate ganglia nerve activity
VNA vagus nerve activity
VF ventricular fibrillation
VT ventricular tachycardia
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Perspectives
Competency in Medical Knowledge
Microneurography is used to directly measure sympathetic nerve activity; however, 
microneurography techniques are difficult to perform and cannot be used in ambulatory 
patients. The results of this study suggest that the SCNA might be a useful method to 
directly measure sympathetic tone in HF, to determine the effects of HF therapy, and to 
determine if cardiac arrhythmias are triggered by sympathetic activation.
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Translational Outlook
Neuromodulation therapy including the ablation of the ganglionated plexi has been used 
for controlling AF. Techniques that can be used as a surrogate for microneurography can 
increase the clinical usefulness of sympathetic nerve activity measurements to help in 
assessing the efficacy of neuromodulation.
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Figure 1. 
Effect of cryoablation on nerve activity before ventricular pacing. Nerve activity was 
quantified by averaging the rectified, high-pass signal every minute for 10 minutes every 
hour for 24 hours. Data before pacing is shown as a box-and-whisker plot comparing the 
control group (Group 1) versus dogs that had stellate ganglion cryoablation (Group 2). A 
significant decrease in nerve activity is seen for the SCNA, SGNA, and VNA in the ablation 
group.
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Figure 2. 
Effect of cryoablation on nerve activity after ventricular pacing. Nerve activity was 
quantified by integrating the rectified, high-pass signal every minute for 10 minutes every 
hour for 24 hours. Data after pacing is shown as a box-and-whisker plot comparing the 
control group (Group 1) versus dogs that had stellate ganglion cryoablation (Group 2). A 
significant decrease in nerve activity is seen for the VNA in the ablation group.
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Figure 3. 
Effect of cryoablation on nerve activity after ventricular pacing. Nerve activity was 
quantified by detecting spikes within the integrated signal. Spikes with an inter-spike 
interval of less than 5 seconds were grouped into bursts. Data after pacing is shown as a box-
and-whisker plot comparing the control group (Group 1) versus dogs that had stellate 
ganglion cryoablation (Group 2). Panel A shows a significant decrease in the amplitude of 
the burst activity is seen in the ablation group for each type of nerve recording. Panel B 
shows the results of calculating the frequency of the bursts. Cryoablation of the stellate 
ganglion did not have a significant effect on the frequency of the bursts of nerve activity.
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Figure 4. 
Atrial tachycardia correlated with an increase in SCNA and SGNA. The arrows indicate the 
increase in nerve activity for the SGNA (A) and the SCNA (B).
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Figure 5. 
Changes in P waves during atrial tachycardia. The onset of tachycardia was preceded by the 
onset of SCNA (red arrow). A morphology change in the p-wave is shown with the onset of 
an atrial tachycardia. The p-wave prior to arrhythmia onset is shown in (a), and the p-wave 
after arrhythmia onset is shown in (b). Also shown is an increase in SGNA and SCNA 
activity correlating to an increase in heart rate.
Shelton et al. Page 17
JACC Clin Electrophysiol. Author manuscript; available in PMC 2019 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 6. 
Correlation of SGNA and SCNA over 24 hours. Relationship between SGNA and the SCNA 
integrated nerve activity (µV) over a 24 hour period for Dog A.
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Figure 7. 
Circadian variation in SCNA. Summary data of the averaged integrated nerve activity (µV) 
for every hour over a 24 hour period for the Control dogs (A) the dogs with cryoablation 
(B).
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Figure 8. 
Generalized additive mixed effect model fitted to the SCNA data. Circadian variation of the 
SCNA in µV for the Control (Group 1) dogs (A) and the dogs with cryoablation (Group 2) 
(B). Solid lines represent mean integrated SCNA calculated over 1 minute for 10 minutes 
every hour. Dotted lines represent 95% upper and lower confidence intervals.
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